2021
DOI: 10.1016/j.clinthera.2020.12.015 View full text |Buy / Rent full text
|
|

Abstract: Purpose: Some classes of glucose-lowering medications, including sodium-glucose co-transporter 2 inhibitors (SGLT2is) and glucagon-like peptide 1receptor agonists (GLP1-RAs) have cardio-protective benefit, but it is unclear whether this influences prescribing in the United Kingdom (UK). This study aims to describe class-level prescribing in adults with type 2 diabetes mellitus (T2DM) by cardiovascular disease (CVD) history using the Clinical Practice Research Datalink (CPRD). Methods: Four cross-sections of pe… Show more

Help me understand this report

Search citation statements

Order By: Relevance
Select...
0
16
0

Publication Types

Select...

Relationship

0
0

Authors

Journals